Investigational Treatment for Atypical Teratoid Rhabdoid Tumors Receives Rare Pediatric Disease Designation
According to a story from Markets Insider, the drug company Kazia Therapeutics Limited recently announced that its investigational therapy paxalisib has been awarded Rare Pediatric Disease designation from the US…